NCT00178958 Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia Status COMPLETED Phase NA
NCT00178932 Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors Status COMPLETED Phase NA
NCT00177580 Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin Status COMPLETED Phase PHASE4
NCT00177008 Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety Status COMPLETED Phase PHASE4
NCT00176436 Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients Status COMPLETED Phase PHASE4
NCT00176423 Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia Status COMPLETED Phase PHASE4
NCT00174447 Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 Status COMPLETED Phase PHASE3
NCT00174265 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) Status COMPLETED Phase PHASE3
NCT00174200 Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone Status COMPLETED Phase NA
NCT00173069 A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) Status UNKNOWN Phase N/A
NCT00172770 The Establishment of the Early Intervention Program for Patients With Schizophrenia Status UNKNOWN Phase N/A
NCT00172731 Measurement of Activity Participation for Persons With Schizophrenia Living in the Community Status COMPLETED Phase N/A
NCT00169702 The Effect of a Weight Management Program During Treatment With Olanzapine Status COMPLETED Phase NA
NCT00169091 Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia Status TERMINATED Phase PHASE4